An upcoming buy-one-get-one-free deal could do wonders for your passive-income stream.

My Best Dividend Aristocrats For November 2022

02:26pm, Wednesday, 26'th Oct 2022
NOBL fell 9.15% in September, which brings the Funds return for the year to a loss of 17.47%. Thus far this month, through October 24th, the dividend aristocrat ETF is up 6.04%, bringing its year-to-d
Elective and deferred surgeries booming during the Covid reopening fell short of projections. This has weighed down the healthcare equipment space. While many names in the space now have reasonable va
Medtronic Plc MDT, +0.98% said Monday it's planning to separate its patient monitoring and respiratory interventions businesses in a move aimed at better positioning both the NewCo and Medtronic for l

2 Stocks to Buy and Forget in This Bear Market

09:15am, Sunday, 23'rd Oct 2022
Both have lagged the market in the past year.
Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.
These stocks may not stay this cheap for long.
These stocks may not stay this cheap for long.
Upgrades According to Jefferies, the prior rating for Target Corp (NYSE:TGT) was changed from Hold to Buy. Target earned $0.39 in the second quarter, compared to $3.64 in the year-ago quarter. The cur

Medtronic (MDT) Gains But Lags Market: What You Should Know

09:50pm, Monday, 17'th Oct 2022 Zacks Investment Research
In the latest trading session, Medtronic (MDT) closed at $82.76, marking a +1.41% move from the previous day.
Value stocks have broken a correlation with inflation expectations, suggesting they have staying power.
DUBLIN , Oct. 14, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the company will host a webcast to provide an update on its Medtronic Coronar

2 Dividend Stocks To Fuel Growth In Your Retirement Income

04:59pm, Thursday, 13'th Oct 2022 Investing.com
Upgrades TD Securities upgraded the previous rating for BCE Inc (NYSE:BCE) from Hold to Buy. In the second quarter, BCE showed an EPS of $0.68, compared to $0.68 from the year-ago quarter. The current

Down Nearly 50%, Is This Growth Stock Still a Buy?

01:23pm, Wednesday, 12'th Oct 2022 The Motley Fool
Intuitive Surgical enjoys a wide moat in the robotic-assisted-surgery space.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE